Proteostasis amends IPO

Proteostasis Therapeutics Inc., Cambridge, Mass. Business: Pulmonary, Endocrine/Metabolic, Neurology Date announced: 2016-02-01 Type: IPO To be raised: Up to $53.9 million Shares: 3.9 million Price: $...